Table 3 Main characteristics of cases and controls, broken down by demographic features, lifestyle habits, underlying pathologies, drug use and influenza vaccination status
From: Do the omeprazole family compounds exert a protective effect against influenza-like illness?
VARIABLES | Cases (n = 254) | Controls (n = 254) | p-value* |
|---|---|---|---|
Demographic features and lifestyle habits | |||
Aged 65 yrs or more^ | 53 (20.9%) | 50 (19.7%) | 0.45 |
Smoking§ | 37 (14.6%) | 45 (17.7%) | 0.40 |
Drinking†§ | 23 (9.1%) | 13 (5.1%) | 0.12 |
Underlying Pathologies | |||
Cardiovascular diseases§ | 14 (5.5%) | 38 (15.0%) | 0.0004 |
Hypertension§ | 56 (22.0%) | 53 (20.9%) | 0.80 |
Respiratory diseases§ | 21 (8.3%) | 21 (8.3%) | 0.87 |
Diabetes§ | 9 (3.5%) | 19 (7.5%) | 0.06 |
Cancer§ | 3 (1.2%) | 5 (2.0%) | 0.72 |
Kidney diseases§ | 7 (2.8%) | 8 (3.1%) | 1.00 |
Dyslipidemia§ | 9 (3.5%) | 45 (17.7%) | <0.0001 |
Gastric ulcer§ | 5 (2.0%) | 29 (11.4%) | <0.0001 |
Gastric diseases§ ǂ | 5 (2.0%) | 14 (5.5%) | 0.07 |
Drugs taken | |||
Fibrates§ | 1 (0.4%) | 8 (3.1%) | 0.046 ** |
Statins§ | 9 (3.5%) | 44 (17.3%) | <0.0001 |
Antibiotics§ | 8 (3.1%) | 5 (2.0%) | 0.58 |
Omeprazole family compounds§ | 19 (7.5%) | 73 (28.7%) | <0.0001 |
Vaccination status | |||
Influenza vaccination§ | 44 (17.3%) | 86 (33.9%) | <0.0001 |